Products
By Team
Sales
Multithread effectively and personalize outreach to convert deals faster
Social Media Marketing
Elevate social presence and drive business growth from social media
RevOps
Identify and prioritize high-intent leads, and improve sales effectiveness
Events & Field Marketing
Find and connect with ICP attendees, and improve event outcomes
Resources
.png)
.png)
Fresenius SE & Co. KGaA
What Does Fresenius SE & Co. KGaA Do?
Fresenius SE & Co. KGaA is a global healthcare group headquartered in Bad Homburg, Germany. The company comprises the operating companies Fresenius Kabi and Fresenius Helios. Fresenius Kabi specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Fresenius Helios is Europe's leading private hospital operator, with operations in Germany (Helios Germany) and Spain (Quirónsalud), as well as Latin America. Fresenius SE & Co. KGaA also holds a strategic investment in Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases. The company is focused on improving patient outcomes and providing high-quality, affordable healthcare solutions worldwide under its #FutureFresenius strategic framework.
Where Is Fresenius SE & Co. KGaA's Headquarters?
HQ Function
The headquarters serves as the central hub for global operations, strategic decision-making, corporate governance, finance, and group-wide management for Fresenius SE & Co. KGaA.
Notable Features:
The campus in Bad Homburg is a modern facility designed to support a collaborative and innovative work environment. It houses key administrative buildings and central corporate functions for the global healthcare group.
Work Culture:
The work culture at Fresenius's headquarters is characterized by a strong focus on healthcare innovation, quality, and patient well-being. It fosters a professional, international, and performance-oriented environment, driven by its mission to advance patient care.
HQ Significance:
The Bad Homburg headquarters is significant as it steers the strategic direction of a major global healthcare player, impacting healthcare delivery and innovation worldwide. It's the historical base from which the company has grown into an international enterprise.
Values Reflected in HQ: The headquarters aims to reflect Fresenius's core values such as entrepreneurial spirit, quality, integrity, patient focus, and innovation through its operational efficiency, sustainability efforts, and the collaborative work conducted within.
Location:
Fresenius SE & Co. KGaA supports a vast range of functions globally through its operating companies and investments. These include research and development of new pharmaceuticals, medical devices, and treatment concepts; manufacturing of sterile injectables, infusion solutions, clinical nutrition products, and dialysis equipment; extensive sales and marketing operations in over 100 countries; operation of hospitals (primarily in Germany via Helios Germany and Spain via Quirónsalud, with presence in Latin America) and dialysis clinics worldwide (via its investment in Fresenius Medical Care); supply chain and logistics management for healthcare products; and comprehensive patient care services across various medical disciplines.
Street Address:
Else-Kröner-Straße 1
City:
Bad Homburg v.d.H.
State/Province:
Hesse
Country:
Germany
Where Else Does Fresenius SE & Co. KGaA Operate Around the World?
Lake Zurich, Illinois/USA
Address: Three Corporate Drive, Lake Zurich, IL 60047, USA
Key hub for Fresenius Kabi's operations in the strategically important U.S. market, managing sales, marketing, R&D, and regulatory affairs for the region.
Waltham, Massachusetts/USA
Address: 920 Winter Street, Waltham, MA 02451, USA
Manages a significant portion of Fresenius Medical Care's global business, providing life-sustaining dialysis treatment and related services to patients in North America.
Madrid/Spain
Address: Calle Zurbarán, 28, 28010 Madrid, Spain (Quirónsalud HQ example)
Manages Helios' extensive hospital network in Spain, focusing on providing high-quality medical care and expanding healthcare services in the Iberian Peninsula and Latin America.
Buying Intent Signals for Fresenius SE & Co. KGaA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Who's Leading Fresenius SE & Co. KGaA? Meet the Executive Team
As of April 2025, Fresenius SE & Co. KGaA' leadership includes:
Who's Investing in Fresenius SE & Co. KGaA?
Fresenius SE & Co. KGaA has been backed by several prominent investors over the years, including:
What Leadership Changes Has Fresenius SE & Co. KGaA Seen Recently?
Fresenius has undertaken strategic leadership changes in the past year, notably with Dr. Michael Moser joining the Management Board as Chief Human Resources and Legal & Compliance Officer, and Wolfgang Kirsch assuming the Chairmanship of the Supervisory Board of Fresenius Management SE. Sebastian Biedenkopf departed from his Management Board role.
Departures
New Appointments:
What Technology (Tech Stack) Is Used byFresenius SE & Co. KGaA?
Discover the tools Fresenius SE & Co. KGaA uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Fresenius SE & Co. KGaA Email Formats and Examples
Fresenius SE & Co. KGaA, like many large corporations, primarily uses a standard email format based on employee names. The most common structure is firstname.lastname@fresenius.com. This format is widely used across its global operations, including its subsidiaries like Fresenius Kabi and Fresenius Helios.
firstname.lastname@fresenius.com
Format
max.mustermann@fresenius.com
Example
90%
Success rate
What's the Latest News About Fresenius SE & Co. KGaA?
Fresenius Official Website • May 7, 2024
Fresenius SE & Co. KGaA starts 2024 with strong first quarter
Fresenius reported strong Q1 2024 results, with organic revenue growth of 6% and EBIT growth of 11% in constant currency. Both Fresenius Kabi and Fresenius Helios contributed to this positive development, and the company confirmed its outlook for the full year 2024....more
Fresenius Official Website • March 4, 2024
Fresenius Kabi launches Tyenne® (adalimumab-aekt) biosimilar in the U.S.
Fresenius Kabi announced the U.S. launch of Tyenne®, its biosimilar to Humira® (adalimumab), for the treatment of multiple chronic inflammatory diseases. This launch expands Fresenius Kabi’s biosimilar portfolio in the U.S., aiming to broaden patient access to critical autoimmune treatments....more
Fresenius Official Website • February 21, 2024
Fresenius SE & Co. KGaA delivers on #FutureFresenius and meets 2023 targets; positive outlook for 2024
Fresenius announced its financial results for 2023, meeting its targets and making significant progress with its #FutureFresenius strategic program. The company provided a positive outlook for 2024, expecting organic revenue growth of 3% to 6% and EBIT growth of 4% to 8% (in constant currency)....more
Highperformr's free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Fresenius SE & Co. KGaA, are just a search away.